September 2017

IL-4–producing B cells shift T cells to Th2 responses

29th September, 2017T helper (Th) 2 cells have been shown to be important in protection against Schistosoma mansoni while increasing susceptibility to Leishmania major. Researchers...

Thandeka MoyoSeptember 29, 2017

breaking news

Type I interferons are important in anti-helminth Th2 immunity

27th September, 2017Type I interferons (IFN) have been traditionally associated with innate immune defences against viruses and bacteria which ultimately result in Th1/17-type...

Thandeka MoyoSeptember 27, 2017

breaking news

Trispecific antibody for HIV therapy

22nd September, 2017One avenue that is being explored in a HIV vaccine is eliciting neutralising antibody responses. However, the diversity of the virus has made this challenging. Researchers from the…

Thandeka MoyoSeptember 22, 2017

breaking news

Antibodies protect against cytomegalovirus infection

20th September, 2017Human cytomegalovirus (HCMV) is a cause of major concern as it causes severe disease in immunocompromised individuals. Therefore, a vaccine to prevent the virus...

Thandeka MoyoSeptember 20, 2017

breaking news

Investigating HIV RNA expression during antiretroviral therapy

18th September, 2017Although antiretroviral therapy (ART) can suppress most HIV replication, the virus establishes reservoirs and these cells may undergo proliferation despite the treatment.

Thandeka MoyoSeptember 18, 2017

Cervical spine MRI showing multiple sclerosis

breaking news

Gut bacteria induce pro-inflammatory response in MS

15th September, 2017Multiple Sclerosis (MS) is a condition which affects the central nervous system. Researchers from Stanford University School of Medicine have now found a link...

Thandeka MoyoSeptember 15, 2017

breaking news

Severity of leishmania infection depends on time of day

13th September, 2017The Leishmania parasite mostly invades neutrophils and macrophages to establish infection. These innate immune cells have internal circadian clocks which...

Thandeka MoyoSeptember 13, 2017

breaking news

Multi-site injections enhance immune responses

11th September, 2017Several approaches to enhance immunity against tumor cells in cancer patients have been proposed. Therapeutic vaccination has been reported to be one of the most...

Thandeka MoyoSeptember 11, 2017

breaking news

Histamine releasing factor makes host vulnerable to malaria

6th September, 2017Malaria has remained major health problem in many developing countries especially sub-Saharan Africa. This has led to the search of an effective vaccine in order...

Thandeka MoyoSeptember 6, 2017

breaking news

Plasmodium infection promotes bone loss

4th September, 2017Malaria disease is the result of infection with Plasmodium parasites. The infection is known to cause some long term adverse effects after the clearance of the parasite including bone…

Thandeka MoyoSeptember 4, 2017

breaking news

Antibodies with incomplete neutralization protect against SHIV

1st September, 2017The in vivo effect of broadly neutralizing antibodies (bnAbs) which are unable to completely neutralize HIV in neutralization assays was poorly understood.

Thandeka MoyoSeptember 1, 2017

IL-4–producing B cells shift T cells to Th2 responses

Type I interferons are important in anti-helminth Th2 immunity

Trispecific antibody for HIV therapy

Antibodies protect against cytomegalovirus infection

Investigating HIV RNA expression during antiretroviral therapy

Gut bacteria induce pro-inflammatory response in MS

Severity of leishmania infection depends on time of day

Multi-site injections enhance immune responses

Histamine releasing factor makes host vulnerable to malaria

Plasmodium infection promotes bone loss

Antibodies with incomplete neutralization protect against SHIV

Advancing Global Online Immunology Education for 20 years

Join our Newsletter

Advancing Global Immunology Education